Zscaler, Inc.’s shares tumbled sharply in Friday’s trading session after its second-quarter results.

Zscaler exceeded expectations with its second-quarter earnings and sales results on Thursday. The company anticipates a fiscal year 2024 non-GAAP income from operations in the range of $395 million to $400 million and net income per share between $2.73 and $2.77.

Zscaler shares witnessed a 10.1% decline to $217.43 on Friday.

Below are notable stocks making moves in the mid-day session today.

Top Gainers

• BioVie Inc. saw its shares surge by 96.1% to $2.4319. BioVie’s Ne3107 exhibited promising enhancements in motor and non-motor symptoms for Parkinson’s disease patients and could potentially reconfigure physiological processes for Alzheimer’s patients.
• Adial Pharmaceuticals, Inc. jumped 68.4% to $3.4350. Adial Pharmaceuticals secured a new patent encompassing AD04 for potentially treating opioid use disorder.
• Cardiff Oncology, Inc. witnessed a 41.5% increase to $2.50 following a robust fourth-quarter financial performance announcement, a clinical update on the Phase 2 ONSEMBLE trial in patients with RAS-mutated mCRC, and the initiation of the randomized first-line RAS-mutated mCRC trial.
• Minim, Inc. noted a 41.4% rise to $6.09 after engaging David Lazar as CEO and CFO following Jeremy Hitchcock’s resignation on Feb. 20.
• The RealReal, Inc. surged by 39.1% to $2.4613 post the release of positive quarterly results.
• Nxu, Inc. climbed 36.4% to $1.09 after successfully charging a Tesla Cybertruck on Feb. 26.
• Jaguar Health, Inc. rose by 35.3% to $0.0798.
• Dell Technologies Inc. increased by 26.3% to $119.52 following an impressive fourth-quarter financial report and a 20% boost in its annual cash dividend.
• Sweetgreen, Inc. gained 26% to $16.05 after exceeding expectations with its fourth-quarter financial performance.
• MMTec, Inc. advanced by 25% to $1.61.
• Everbridge, Inc. rose by 24.5% to $35.19 after amending and restating its previously announced merger agreement with Thoma Bravo.
• NetApp, Inc. saw a 24.4% increase to $110.85 post the announcement of better-than-expected third-quarter financial results and guidance.
• Xponential Fitness, Inc. climbed 24% to $12.50 following robust quarterly sales.
• Myomo, Inc. gained 21.9% to $3.73.
• Ventyx Biosciences, Inc. soared by 20.1% to $8.50.
• MSP Recovery, Inc. jumped by 18.8% to $1.01.
• Opera Limited rose by 18.8% to $14.47 spurred by strong sales.
• REGENXBIO Inc. advanced by 18.5% to $20.66.
• RadNet, Inc. surged by 18.1% to $44.71 driven by a solid quarterly performance.
• Sana Biotechnology, Inc. witnessed a 17.3% upswing to $11.78 after showcasing a year-over-year increase in fourth-quarter financial results.
• Tidewater Inc. gained 15.3% to $80.73 following its fourth-quarter financial results.
• Y-mAbs Therapeutics, Inc. saw a 14.3% increase to $19.09 after surpassing fourth-quarter financial expectations.
• Repay Holdings Corporation rose by 14.4% to $9.94 driven by strong quarterly results.
• Root, Inc. surged by 14.2% to $36.66 after Jefferies analyst Yaron Kinar upgraded the stock from Hold to Buy and raised the price target to $40.
• MasTec, Inc. rose by 11.2% to $83.89 post strong quarterly results.
• Rambus Inc. climbed 9.3% to $64.76 after initiating an accelerated share repurchase program to buy back $50 million of its common stock.
• Arvinas, Inc. rose by 9.2% to $50.21 after Barclays analyst Peter Lawson maintained the stock.